Tang Lab

Laboratory of Biomaterials for Immunoengineering

© Alban Kakulya

Leenaards Foundation announces two winners of its 2025 Science Prize

See more

Two research groups in the Lake Geneva region have been selected for the 2025 Leenaards Science Prize. One of the research groups, led by Prof. Li Tang at EPFL, is exploring a new approach to overcoming cancer-cell resistance to immunotherapy. The idea is to increase the stiffness of cancer cells, making it easier for patients’ own T-cells to attack and destroy the tumors. This approach, which combines mechanical engineering with biology and clinical practice, could lead to more effective treatments for patients who are resistant to existing types of immunotherapy.

Our research

Our immune system is constantly defending us from many diseases through profound interactions with invaders or diseased cells. Such interactions are multi-dimensional, meaning that extensive biological, chemical, and physical exchanges are involved. With that in mind, the team of Tang Laboratory is developing novel strategies to engineer such multi-dimensional immunity-disease interactions from various aspects, an emerging field called ‘immunoengineering’, in order to create safe and effective therapies against cancer and infectious diseases.

Contact

Head of Laboratory : Li Tang
EPFL-STI-IBI/IMX-LBI
MED 1 2826, Station 9
CH-1015 Lausanne, Switzerland
Phone : +41 21 693 0937
Email: li.tang@epfl.ch


Administrative Assistant : Monica Navarro Suarez
EPFL-STI-IBI/IMX-LBI
MED 1 2726, Station 9
CH-1015 Lausanne, Switzerland
Phone : +41 21 693 0756
Email: monica.navarro@epfl.ch


Access map